Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucocil is a **dietary supplement** formulated to promote healthy blood sugar levels and support metabolic health. It is a proprietary blend of 14 ingredients, including mulberry leaf extract, berberine, alpha lipoic acid, chromium picolinate, cinnamon bark, gymnema sylvestre, banaba, veld grape extract, vitamins B1, B6, B12, D3, fish oil, and turmeric. The mechanisms by which Glucocil acts are: reducing sugar absorption in the intestines (primarily via mulberry leaf extract), decreasing hepatic glucose production (notably through berberine and alpha lipoic acid), and enhancing insulin sensitivity and glucose uptake (notably through chromium, berberine, alpha lipoic acid, and gymnema). Glucocil also supports cardiovascular health, healthy weight management, and overall metabolic function. It is not an FDA-approved pharmaceutical drug, but rather is regulated as a dietary supplement in the United States[2][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Glucocil.